NCT05641285 is a clinical trial of The OtoSight Middle Ear Scope in Ear Infection, sponsored by Baylor College of Medicine.

Who is sponsoring NCT05641285?

NCT05641285 is sponsored by Baylor College of Medicine.

What drugs are being tested in NCT05641285?

Interventions in NCT05641285: The OtoSight Middle Ear Scope.

What condition does NCT05641285 study?

NCT05641285 studies Ear Infection, Middle Ear Infection, Otitis Media.

Is NCT05641285 still recruiting?

NCT05641285 is currently active, enrolled. Last updated 31 October 2024.

Last reviewed 2024-10-31 · How we verify

NCT05641285

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic Utility of Otosight Middle Ear Scope

Active, enrolled Last updated 31 October 2024

What this trial tests

trial testing The OtoSight Middle Ear Scope in Ear Infection in 165 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

21 February 2023

Primary endpoint
29 June 2023

30 June 2025

Quick facts

Lead sponsor	Baylor College of Medicine
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	165
Start date	21 February 2023
Primary completion	29 June 2023
Estimated completion	30 June 2025
Sites	1 location across United States

Drugs / interventions tested

The OtoSight Middle Ear Scope

Conditions studied

Ear Infection — all drugs for Ear Infection →
Middle Ear Infection — all drugs for Middle Ear Infection →
Otitis Media — all drugs for Otitis Media →

Sponsor

Baylor College of Medicine

Who can join

Adults 6 Months to 12, any sex, with Ear Infection or Middle Ear Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate clinic workflow impact of OtoSight use for patients seen in the pediatric otolaryngology clinic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ear Infection

Currently open trials in the same condition.

NCT06429709 — Utility of Advanced Ultrasound Otoscope In The Diagnosis of AOM · active not recruiting

Other Baylor College of Medicine trials

Trials by the same sponsor.

NCT07513194 — GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT) · Phase 1 · not yet recruiting
NCT05855824 — Toddler Biomarker of Nutrition Study · NA · not yet recruiting
NCT06738628 — Disposable Endoscope Platform in Third Space Endoscopic Procedures · not yet recruiting
NCT06834997 — Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital · Phase 2 · withdrawn
NCT07387614 — WEB-BASED SUPPORT PROGRAM FOR CAREGIVERS OF VETERANS WITH DEMENTIA DISCHARGED FROM SKILLED NURSING FACILITIES TO HOME · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05641285 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Baylor College of Medicine
Last refreshed: 31 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05641285.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing